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Summary: An attenuated |3~adrenergic vasodilation of 
small arteries may help explain the increased peripheral 
resistance in hypertension. To investigate this, we com­
pared the isoprenaline-induced relaxation of mesenteric 
resistance arteries of spontaneously hypertensive rats 
(SHR) and Wistar-Kyoto rats (WKY) using a small vessel 
myograph. The arteries had similar diameters, but the 
contractile force induced by cumulative addition of K + 
(10-130 niM) was 1,3-fold higher for the SHR. The (J- 
adrenoceptor-mediated relaxation of arteries* precon­
tracted with 40 mA/ K 1 , was significantly less in SHR (41 
± 3%, n -  11) than in WKY (56 it 3%, n -  15, p = 
0.003), and the pD2 value for isoprenaline was signifi­
cantly lower in SHR (7.13 £ 0.09 vs, 7,41 ± 0.07, p ~ 
0.02). In contrast, when precontracted with phenyleph­
rine (PE, exr adrenoceptor agonist, 3-10 |xM), isoprena­
line relaxation was almost complete in both SHR and 
WKY, and the pD2 value for isoprenaline did not differ 
between strains, Forskolin induced complete relaxation 
of both precontractions. Because the (3-adrenergic relax­
ation of the mesenteric resistance arteries was attenuated 
only after K^-precontraction, we conclude that alter­
ations in this precontracting mechanism in SHR rather 
than a defect in the (3-adrenoceptor system may provide 
an explanation for the decreased relaxation in these ves­
sels, Intracellular Ca2+ measurements and a review of 
the literature support this conclusion. Key Words: 0 -Ad- 
renergic relaxation— M esenteric resistance arteries—  
Isoprenaline— Forskolin— Spontaneously hypertensive 
rats— Intracellular Ca2* concentration—Precontraction.
Increased peripheral vascular resistance (PVR) is 
common in hypertension (1). Because stimulation 
of p-adrenoceptors on the smooth muscle cells 
(SMC) of the vascular wall results in vasodilation, a 
blunted (3-adrenergic response may help explain the 
increased peripheral resistance of the blood vessels 
in hypertension (2,3). Alterations in the (3-adreno­
ceptor system in hypertension have been investi­
gated quite extensively. For most of these studies, 
animal models of hypertension, such as the sponta­
neously hypertensive rat (SHR), have been used. In 
studies of conduit arteries of SHR, such as aorta 
and femoral artery, Cohen and Berkowitz (4) and 
Asano and co-workers (5-10) showed that the (i-ad- 
renergic responsiveness was decreased. The main
part of the vascular resistance, however, is gener­
ated in the smaller arteries or resistance vessels
(11). Therefore, these vessels appear to be more 
appropriate for investigation of alterations in (3-ad- 
renergic responsiveness in hypertension. In the 
present study, we examined the (3-adrenoceptor- 
mediated relaxation in mesenteric resistance arter­
ies from SHR and Wistar-Kyoto rats (WKY) with 
the 3-adrenoceptor agonist isoprenaline.
The contraction and relaxation of vascular SMC 
(VSMC) is the result of a change in the intracellular 
Ca2 + concentration ([Ca2 + ];) or a modulation of the 
sensitivity of the contractile apparatus to Ca2+ (12). 
The contraction of mesenteric resistance arteries 
with K + has been shown to be mainly the result of
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an increase in [Ca2'4']*, whereas phenylephrine (PE, 
a r adrenoceptor agonist) mainly induces a sensiti­
zation to Ca2+ (13). To determine the influence of 
these different mechanisms of contraction on the 
(3-adrenoceptor-mediated relaxation, we con­
tracted the arteries with either K + or PE and then 
exposed them to isoprenaline. The- effect of K+ , 
PE, isoprenaline and forskolin on the intracellular 
Ca2"1“ concentration of VSMC muscle cells was in­
vestigated by digital imaging microscopy of Fura-2- 
loaded mesenteric resistance arteries from WKY.
MATERIALS AND METHODS 
Materials
Isoprenaline was purchased form Lansberg B V (Uden, 
The Netherlands), PE from Genfarm BV (Maarssen, The 
Netherlands), and forskolin and dibutyryl cyclic AMP 
from Sigma (St. Louis, MO, U .S.A .). Fura-2 AM and 
pluronic FI27 were obtained from Molecular Probes (Eu­
gene, OR, U .S.A .). All other reagents were of analytical 
quality,
Preparation of the mesenteric arteries
Male SHR and WKY were obtained from Harlan Oiac, 
Bicester, U.K. At the age of 12-18 weeks, the rats were 
killed by cervical dislocation. The intestine was removed 
and stored for <24 h at 4°C in phosphate-buffered saline 
solution (PSS: NaCl 120 mM, KC14.7mM, CaCl2 2.5 mM, 
N aH C 03 25 mM, KH2P 0 4 1.2 mM, MgCl2 1.17 mM, 
EDTA 2.7 \hM, and glucose 5.5 mM). Storage of the in­
testine for =524 h did not affect any of the properties de­
termined in this study. Parts of the small intestine, 7-15 
cm from the stomach, were fixed on a wax plate and 
submerged in PSS. Side branches of the superior mesen­
teric artery were dissected and mounted on a small vessel 
myograph as described by Mulvany and Halpern (11). 
Two stainless-steel wires (diameter 40 fxm) were inserted 
into the lumen of the resistance arteries. The wires were 
mounted between an isometric force transducer (Kistler 
Morse DSC 6 , Seattle, WA, U.S.A.) and a displacement 
device (Mitatoyo, Tokyo, Japan) in a 10-ml organ cham­
ber. The organ chamber was filled with PSS solution 
maintained at 37°C and continuously aerated with 95% 
0 2/5% CO2 (pH 7.4). After equilibration for 1 h at 37°C, 
the arteries were set to a normalized internal circumfer­
ence (Lj), estimated to be 0.9 times the circumference 
they would maintain if relaxed and exposed to a transmu­
ral pressure of 100 mm Hg (L100), a procedure described 
in detail by Mulvany and Halpern (11»). The mean internal 
diameter at 100 mm Hg was 238 ±  39 }im (n = 11, mean 
± SD) and 246 ±  67 |xm (n = 15) for SHR and WKY, 
respectively, which is characteristic for resistance vessels 
(11). The arteries mounted in the myograph were 1,8-2.0 
mm long.
Contraction and relaxation of resistance arteries
After normalization, the resistance arteries were con­
tracted for 1 min by exchanging the PSS for K-PSS, in 
which all NaCl was replaced by KC1 (total K + concen­
tration 125 mM), followed by rinsing twice with PSS and 
repeated after 15 min. A cumulative concentration- 
response curve was recorded by increasing the K +- 
concentration stepwise from 10 to 125 mM  K + . After two
washes in 15 min, the arteries were contracted with a 
mixture of 30% K-PSS and 70% PSS (total K + concen­
tration 40 mM), which gave precontractions of 70-90% of 
the maximal contractions observed in the concentratioiv- 
response curves. The relaxing effect of isoprenaline was 
then studied by a stepwise increase in their concentration 
(10 nM  to 3.2 fxM); after the washing procedure, a con« 
centration-response curve for forskolin was recorded (10 
nM  to 3.2 |xM). The effect of PE precontraction on the 
isoprenaline relaxation was studied by contracting the ar­
teries with 3 |ulM  PE; when no stable contraction was 
obtained, the PE concentration was increased to 10 jxM. 
When the response continued to be unstable, the artery 
was not used further (n = 3 in both SHR and WKY). The 
relaxing effect of isoprenaline was studied as already de­
scribed. All experiments were executed in the same order 
because pilot experiments showed no effect of the se­
quence of precontractions on the parameters deter mined 
in this study.
[Ca2+]i measurements with mesenteric 
resistance arteries
Mesenteric arteries for the [Ca2+]{ measurements were 
prepared in the same way as for the myograph studies. 
After a mesenteric resistance artery was mounted in the 
myograph, a glass capillary (diameter MOO fun) was 
gently inserted in the lumen to stretch the artery. Insert­
ing a glass capillary into the arterial lumen appeared to be 
crucial because no changes in [Ca2+]i could be observed 
without it, The artery was then removed from the myo­
graph and placed in a small plastic tube containing PSS 
with 10 pJVf Fura-2-AM and 1 \xM pluronic FI27 (total 
volume 500 fxl) followed by incubations at room temper­
ature for 2 h in the dark. The incubation solution was then 
changed, followed by a second incubation for 2 h, in 
which the artery was transferred to a thermostated (30°C) 
perfusion chamber (Leiden chamber). The incubation 
volume was —300 |xl. The tissue was superfused at a flow 
rate of 1 ml/min with PSS and thoroughly gassed with 
95% 0 2/5% C 02. The test substances were dissolved in 
the medium and delivered to the tissue by means of su­
perfusion. To remove nonhydrolyzed Fura-2-AM, the tis­
sue was superfused with PSS for 15 min. After this equil­
ibration period, fluorescence measurements were started 
as previously described (14). The chamber was placed on 
the stage of an inverted microscope (Nikon Diaphot). The 
light from a 100-W xenon lamp was directed through a 
quartz neutral density filter (Ealing Electro-Optics, Hol- 
liston, MA, U.S.A.) with a density 5=1.5 through excita­
tion filters, mounted in a motor-driven rotating filter 
wheel, with transmission maxima at 340 and 380 nm (± 12 
nm) (Ealing Electro-Optics). Dynamic video imaging of 
part of the artery was performed with a charge-coupled 
device (CCD) camera (Photonics Sciences) with MagiCal 
hardware and TARDIS software provided by Joyce Loebl 
(Dukesway, Team Valley, Gateshead, Tyne & Wear, 
U.K.) as described in detail by Neylon and colleagues 
(15). The fluorescence emission ratio at 492 nm, corrected 
for autofluorescence, was monitored as a measure of 
[Ca2_h]i after excitation at 340 and 380 nm (16).
Data analysis
The concentration-response curves were analyzed by 
GraphPad, a nonlinear curve fitting program (GraphPad, 
Institute for Scientific Information, San Diego, CA,
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FIG. 1. Concentration-response curve for the contraction of 
mesenteric resistance arteries from spontaneously hyperten­
sive rats (SHR, solid line, n = 11) and Wistar-Kyoto rats 
(WKY, dashed line, n = 15) to cumulative addition of K+. 
Curves were constructed by fitting the averaged data from 
the individual experiments. Error bars indicate SE.
U.S.A.). Sensitivities to drugs, expressed as pD2 values, 
and maximal effects were calculated on the basis of data 
from  individual arteries. The responses to relaxing agents 
were expressed as the absolute decrease in tension (mN) 
and as a percentage of the precontraction. The data are 
mean ± SE. The results were analyzed statistically with a 
two-sample Wilcoxon rank sum test for comparison of the 
SHR and WKY arteries, and a paired Wilcoxon signed- 
rank test for comparison of the different precontractions. 
A p-value <  0.05 (two-sided) was considered statistically 
significant, insignificant differences are indicated by NS 
in the text.
RESULTS
Concentration-response curves for K+
A cumulative increase in K + concentration in­
duced a concentration-dependent contraction of the 
mesenteric resistance arteries, as shown in Fig. 1. 
The maximal contractile force was 7.1 ± 0.5 mN (n 
= 11) for SHR arteries and 5.5 ± 0.7 mN (n = 15) 
for WKY arteries, a difference which was statisti­
cally significant (p = 0.03). The pD2 values for K+ 
were 1.33 ± 0.04 and 1.35 ± 0.03 (NS) for SHR and 
WKY, respectively.
Relaxation of the arteries with isoprenaline 
Isoprenaline-mediated relaxations were studied 
after precontraction of the arteries with 40 mM  K + ,
a precontraction that was stable for at least 40 min. 
As shown in Fig. 2A, the precontraction was 
slightly but insignificantly greater in arteries from 
SHR. The absolute isoprenaline-mediated relax­
ation (in mN) was not significantly different be­
tween the two groups. However, when expressed 
as a percentage of the precontraction with 40 mM  
K + (Fig, 2B and Table 1), a significant attenuation 
of the relaxing effect of isoprenaline was observed 
in SHR as compared with WKY. The pD2 value for 
isoprenaline was significantly lower in the SHR ar­
teries, precontracted with 40 mM  K + (Table 1).
To study the influence of the nature of precon­
traction on isoprenaline-mediated relaxations, we 
also used the c^-selective adrenergic agonist phen­
ylephrine (17) as a precontracting agent. The con­
traction induced by PE (3-10 jxM in PSS) was sig­
nificantly stronger than the response to K + in WKY 
arteries, but significantly weaker in SHR arteries 
(Table 2). PE induced an oscillating contraction in 
all arteries tested, a phenomenon which was also 
observed with oxymethazoline, norepinephrine, 
and serotonin (data not shown). In some of the 
preparations (3 of 11 SHR, 3 of 15 WKY) the PE 
response was transient and did not reach sufficient 
stability to allow study of the isoprenaline-mediated 
relaxation. In contrast to K + precontraction, the 
(3-adrenoceptor-mediated relaxation was almost 
complete in PE-precontracted arteries (Fig. 3A). 
The relative relaxation shown in Fig. 3B was similar 
in SHR and WKY, although the concentration- 
response curve for WKY was shifted to the right. 
This resulted in a tendency toward a higher pD2 
value for isoprenaline in SHR (Table 1), which just 
failed to reach statistical significance.
Relaxation of the mesenteric resistance arteries 
with forskolin
Cumulative addition of forskolin induced an al­
most complete relaxation of mesenteric resistance 
arteries precontracted with 40 mM  K + . As shown 
in Table 1, no marked differences in forskolin- 
mediated relaxation were evident between SHR and 









FIG. 2, Relaxation of mesenteric resistance 
arteries, precontracted with 40 mM K+, by 
cumulative addition of isoprenaline. Sponta­
neously hypertensive rats (SHR, solid line, n 
= 11), Wistar-Kyoto rats (WKY, dashed line, 
n -  15). A: Absolute relaxation. B: Relax­
ation expressed as a fraction of the precon­
traction. C, Force in the absence of isopren- 
aline. Error bars represent SEM.
l o g  [ i s o p r e n a l i n e ] lo g  [ i s o p r e n a l i n e ]
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T A B L E  1. C o m p a r is o n  o f  th e  r e la x a t io n s  in d u c e d  b y  iso p re n a lin e  a n d  fo r s k o l in  in S H R  a n d  W K Y  m e s e n te r ic
r e s is ta n c e  a r te r ie s
Relaxation SHR WKY p-V aluc
Isoprenaline
K + pre contraction
5.7 ±  0.5 5.2 ± 0.3 NSPrecontraction (mN)
M axim um  relaxation (mN) 2.3 ± 0.2 2.9 ±  0.5 NS
M axim um  percentage of relaxation 41 ±  3 56 ±  3 0.003





6.5 ±  1.0 NSPrecontraction (mN)
M aximum relaxation (mN) 4.4 ±  0.7 6.2 ±  1.1 NS
M aximum percentage of relaxation 93 ±  2 91 ±  3 NS




4.3 ±  0.4 NSPrecontraction (mN) 4.8 ±  0.4
M aximum relaxation (mN) 4.0 ±  0.4 3.7 ±  0,8 NS
M aximum percentage of relaxation 81 ±  3 84 ±  2 NS
pD2 (M) 7.08 ±  0.12 7.01 ±  0.13 NS
n 11 15
SHR, spontaneously hypertensive rats; W K Y , W istar-Kyoto rats; PE, phenylephrine.
Data are mean ±  SE calculated on the basis o f the results of curve fits from individual arteries, with statistical analysis by Wilcoxon 
rank-sum test for unpaired samples,
arteries precontracted with PE (data not shown),
[Ca2+]i measurements 
Measurements of the intracellular Ca2+ concen­
tration were performed under conditions similar to 
those in the myograph. Loading of the arteries with 
Fura-2 resulted in fluorescent staining of the SMC 
spanning the arterial lumen. A tracing of a [Ca2+]i 
measurement is shown in Fig. 4. Superfusion with 
40 mM  K + induced an increase in the 340/380 ratio 
from 0.87 ± 0.10 to 0.98 ± 0,12 (n = 4); this in­
crease was rapidly reversible by superfusion with 
PSS. Superfusion with PE (10 |xM )  resulted in an 
average increase in the basal 340/380 ratio of 0,05 in 
three experiments, whereas in a fourth experiment 
no increase in ratio was detected. In three experi­
ments, isoprenaline (10 ¡xM) was added to the su- 
perfusate while the 340/380 ratio was increased with 
40 rnM K + , but this did not induce a decrease in the
ratio. Similar results were obtained with forskolin 
(10 \iM )  and dibutyryl-cyclicAMP (100 (xA/)-
DISCUSSION
In the present study, the vasorelaxant properties 
of the |3-adrenoceptor system of mesenteric resis­
tance arteries of SHR and WKY rats were com­
pared. To our knowledge, this is the first time that 
this receptor system has been studied in resistance 
vessels, which contribute strongly to vascular resis­
tance and are therefore of primary interest in hy­
pertension research.
The maximal contraction of the mesenteric resis­
tance arteries, induced by K + , was significantly 
higher in SHR as compared with WKY. This finding 
, is in agreement with results of other studies (8-10) 
in which strips of conducting arteries, mainly fem­
oral arteries, from SPIR and WKY were used.
T A B L E  2 . E f f e c t  o f  d i f fe r e n t  p r e c o n tr a c t io n s  on  the re la x in g  p r o p e r t i e s  o f  iso p re n a lin e
Param eter K  + PE p-Value
SH R  (n =  8)
Precontraction (mN) 5.8 ±  0.5 4.7 ±  0.6 0,005
M aximum relaxation (mN) 2.4 ±  0.2 4.4 ± 0.7 0.001
M axim um  percentage o f  relaxation 41 ±  3 93 ±  2 0.007
pD  2 (M) 7.14 ±  0.Q7 7.05 ±  0.11 NS
W KY (n =  12)
Precontraction  (mN) 5.6 ±  0.8 6.5 ± 1.0 0.003
Relaxation (mN) 3.1 ±  0.5 6,2 ±  1.1 0,001
Relaxation (%) 56 ±  3 91 ± 3 0.001
p l>2 {M) 7.37 ±  0.05 6.76 ± 0 .1 1 0.001
A bbreviations as in Table 1.
Statistical analysts by W ilcoxon signed-rank test for paired observations.
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FIG. 3. Relaxation of mesenteric resistance arteries precon­
tracted with 3-10 fj»M phenylephrine by cumulative addition 
of isoprenaline. Spontaneously hypertensive rats (SHR, solid 
line, n -  8); Wistar-Kyoto rats (WKY, dashed line, n = 12). 
Details as in legend to Fig, 2.
These results indicate that both in conducting arter­
ies and in resistance arteries of SHR, an abnormal­
ity exists, causing an increased K +-induced con­
tractile force. Besides an increased ratio of wall to 
lumen in SHR, Kojima and associates (18) de­
scribed a malfunction of the sarcoplasmic reticulum 
(SR) in femoral arteries from SHR as compared 
with WKY that leads to an increased intracellular 
Ca2+ concentration on contractile stimulus.
In tissues from SHR and WKY precontracted 
with 40 m M  K + , cumulative addition of isoprena­
line induced a partial relaxation of the mesenteric 
resistance arteries. In a previous study, we showed 
that this relaxation was not the result of a release of 
endothelium-derived relaxing factor (EDRF) and 
therefore is probably the result of a direct stimula­
TIME (s)
FIG. 4. Tracing of a measurement of the intracellular Ca2 + 
concentration in smooth muscle cells of a mesenteric resis­
tance artery from Wistar-Kyoto rats (WKY). The artery was 
loaded with Fura-2-AM for 4 h. On the /-axis, the ratio be­
tween the emission of the Ca2+-sensitive dye after excitation 
with light from 340 and 380 nm (340/380 ratio), a measure for 
the intracellular Ca2+ concentration, is shown. Unless indi­
cated otherwise (top) the artery was superfused with phos- 
phate-buffered saline solution 1 ml/min aerated with 95% 02i 
5%C02. Superfusion with K + induced an increase in 340/380 
ratio (K+ 40 = 40 mM K + ; K+ 125 = 125 mM K + ) that could 
not be reversed with isoprenaline (ISO, 10 jjiM) or forskolin 
(FORSK, 10 \xM), Phenylephrine (10 \xM) induced only a slight 
increase in 340/380 ratio as compared with K+.
tion of (3-adrenoceptors on VSMC (19). When ex­
pressed as a fraction of the precontraction, the iso- 
prenaline-induced relaxation was significantly less 
in SHR arteries. Moreover, the pD2 value for iso­
prenaline was significantly lower in SHR as com­
pared with WKY. These results are similar to those 
of Cohen and Berkowitz (4) and Asano and co­
workers (5-10) in studies of conducting arteries of 
SHR, in which the p-adrenoceptor mediated relax­
ation was expressed as a fraction of the papaverine- 
induced relaxation.
To investigate the effect of the type of precon­
traction on the p-adrenergic relaxation, the a r  
adrenoceptor agonist PE was also used as a precon­
tracting agent. The compound induces contraction 
through inositol phospholipid metabolism (20), 
without the a r adrenoceptor-mediated inhibition of 
cyclicAMP production (21). Because the latter 
would interfere with the isoprenaline-mediated 
stimulation of cyclicAMP production, it would 
hamper the interpretation of the experiments. When 
the mesenteric resistance arteries from either SHR 
or WKY were precontracted with PE, isoprenaline 
could almost completely relax them, and no differ­
ence in relaxation was observed between the two 
groups. Moreover, the pD2 value for isoprenaline 
was no longer decreased in SHR. These results in­
dicate that the (3-adrenoceptor-mediated relaxation 
is dependent on the type of precontraction used. 
These results are in agreement with the data of Abe 
and Karaki (22), who showed that dibutyryl cyclic 
AMP could relax rat aorta strips more effectively 
after a-adrenoceptor-mediated precontraction than 
after depolarization with K + .
The stronger isoprenaline-mediated relaxation of 
PE-precontracted arteries as compared with K +- 
precontracted arteries may be explained by the 
mechanisms by which these compounds induce 
contraction. Jensen and colleagues (13) showed that 
K H_ induces contraction of mesenteric resistance ar­
teries mainly by increasing the intracellular Ca2+ 
concentration, whereas norepinephrine induces 
contraction mainly by increasing the sensitivity of 
the contractile apparatus for Ca2 + . Relaxation by 
cyclicAMP-generating agents can result from a de­
sensitization of the contractile apparatus to Ca2+
(12); in the present study, this finding was sup­
ported by the measurements of the intracellular 
Ca2+ concentration in WKY. Therefore, the atten­
uated isoprenaline-mediated relaxation observed in 
SHR arteries precontracted with K + is more likely 
to result from an increased contraction of these ar­
teries to K + than from a defect in the (3-adrenergic 
system. At 40 mM  K +, the SHR arteries tend to con­
tract more strongly than those of WKY, which can be 
explained by a malfunction of the SR (18). Due to this 
malfunction, K + induces a stronger increase in the 
intracellular Ca2 + concentration in SHR arteries,
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which can less effectively be counteracted by iso- 
prenaline, leading to an attenuated isoprenaline- 
induced relaxation of SHR arteries with the com­
pound. Although one of the limitations of our study 
is that the [Ca2+], measurements were made only in 
WKY arteries, we suggest that the attenuated (3-ad­
renergic relaxation in SHR arteries precontracted 
with K + is better explained by an alteration in in­
tracellular Ca2+ handling in SHR arteries than by a 
defect in the (J-adrenergic system itself. This finding 
is in agreement with recent reports concerning 13- 
adrenoceptor density and function in human pri­
mary hypertension (23,24), in which no alterations 
in this receptor system were noted.
The p-adrenergic relaxation of mesenteric resis­
tance arteries from SHR was attenuated after pre­
contraction with K +. This finding could not be re­
produced with a PE precontraction and can proba­
bly be explained by the reported malfunction of the 
SR in SHR arteries. The |3-adrenergic relaxation it­
self is likely to be unaltered in mesenteric resistance 
arteries of SHR.
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